{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:34:10Z","timestamp":1790663650787,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>To outline the latest discoveries regarding the utility and reliability of serum biomarkers in idiopathic recurrent acute pericarditis (IRAP), considering recent findings on its pathogenesis. The study highlights the predictive role of these biomarkers in potential short- (cardiac tamponade, recurrences) and long-term complications (constrictive pericarditis, death).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>The pathogenesis of pericarditis has been better defined in recent years, focusing on the autoinflammatory pathway. New studies have demonstrated the pivotal role of the classical inflammatory biomarkers in distinguishing pericarditis phenotypes (high-grade vs. low-grade inflammation) and in defining outcomes of this condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Pericarditis involves intense inflammatory activity, which causes elevation of different markers, such as C-reactive protein, erythrocyte sedimentation rate, neutrophils and platelets, serum amyloid A and D-Dimer. Conversely, lymphocytes are often reduced, as well as hemoglobin during the acute phase. Cardiac troponins T and I are elevated in up to 30% of cases. A Biomarker for CRP-negative cases is needed. Other markers have been proposed for diagnosis and prognosis in IRAP, such as anti-heart antibodies and anti-intercalated disk antibodies, but we need further studies to validate them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-024-02170-y","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T06:24:29Z","timestamp":1736576669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5517","authenticated-orcid":false,"given":"Ruggiero","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-5866","authenticated-orcid":false,"given":"Emanuele","family":"Bizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Facoetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Colazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"21","key":"2170_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMcp041997","volume":"351","author":"RA Lange","year":"2004","unstructured":"Lange RA, Hillis LD. Clinical practice. Acute pericarditis [published correction appears in N Engl J Med. 2005;352(11):1163]. N Engl J Med. 2004;351(21):2195\u20132202. https:\/\/doi.org\/10.1056\/NEJMcp041997","journal-title":"N Engl J Med"},{"issue":"12","key":"2170_CR2","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.jacc.2003.02.001","volume":"42","author":"M Imazio","year":"2003","unstructured":"Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003;42(12):2144\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2003.02.001.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2170_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1378\/chest.122.3.900","volume":"122","author":"LJ Burgess","year":"2002","unstructured":"Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest. 2002;122(3):900\u20135. https:\/\/doi.org\/10.1378\/chest.122.3.900.","journal-title":"Chest"},{"issue":"1","key":"2170_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/172460080502000107","volume":"20","author":"M Szturmowicz","year":"2005","unstructured":"Szturmowicz M, Tomkowski W, Fijalkowska A, et al. Diagnostic utility of CYFRA 21\u2013\u20091 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. Int J Biol Markers. 2005;20(1):43\u20139.","journal-title":"Int J Biol Markers"},{"issue":"3","key":"2170_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2459\/JCM.0b013e328322f9b1","volume":"10","author":"M Imazio","year":"2009","unstructured":"Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10(3):217\u201330. https:\/\/doi.org\/10.2459\/JCM.0b013e328322f9b1.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"2170_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2019.11.02","volume":"75","author":"JG Chiabrando","year":"2020","unstructured":"Chiabrando JG, Bonaventura A, Vecchi\u00e9 A, et al. Management of Acute and recurrent pericarditis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(1):76\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.02.","journal-title":"J Am Coll Cardiol"},{"issue":"42","key":"2170_CR7","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the diagnosis and management of Pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J. 2015;36(42):2921\u201364. https:\/\/doi.org\/10.1093\/eurheartj\/ehv318.","journal-title":"Eur Heart J"},{"issue":"3","key":"2170_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018;243(3):213\u201321. https:\/\/doi.org\/10.1177\/1535370217750088.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2170_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/injms.injms_60_21","volume":"13","author":"F Selvi","year":"2022","unstructured":"Selvi F, Korkut M, Bedel C. Immature granulocytes: a novel biomarker of acute pericarditis. Indian J Med Specialities 2022;13(1):33\u20136. https:\/\/doi.org\/10.4103\/injms.injms_60_21","journal-title":"Indian Journal of Medical Specialities"},{"issue":"2","key":"2170_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/1756-185X.14523","volume":"26","author":"E Tombetti","year":"2023","unstructured":"Tombetti E, Casarin F, Bizzi E, et al. Relapsing pericarditis: peripheral blood neutrophilia, lymphopenia and high neutrophil-to-lymphocyte ratio herald acute attacks, high-grade inflammation, multiserosal involvement, and predict multiple recurrences. Int J Rheum Dis. 2023;26(2):337\u201343. https:\/\/doi.org\/10.1111\/1756-185X.14523.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"2170_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/eci.12711","volume":"47","author":"G Lazaros","year":"2017","unstructured":"Lazaros G, Antonopoulos AS, Oikonomou EK, et al. Prognostic implications of epicardial fat volume quantification in acute pericarditis. Eur J Clin Invest. 2017;47(2):129\u201336. https:\/\/doi.org\/10.1111\/eci.12711.","journal-title":"Eur J Clin Invest"},{"key":"2170_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejim.2023.06.017","volume":"116","author":"G Lazaros","year":"2023","unstructured":"Lazaros G, Vlachakis PK, Theofilis P, et al. D-dimer as a diagnostic and prognostic plasma biomarker in patients with a first episode of acute pericarditis. Eur J Intern Med. 2023;116:58\u201364. https:\/\/doi.org\/10.1016\/j.ejim.2023.06.017.","journal-title":"Eur J Intern Med"},{"issue":"22","key":"2170_CR13","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/heartjnl-2011-300054","volume":"97","author":"M Imazio","year":"2011","unstructured":"Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97(22):1882\u201392. https:\/\/doi.org\/10.1136\/heartjnl-2011-300054.","journal-title":"Heart"},{"issue":"35","key":"2170_CR14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio ALP, Adler Y, Agostini C, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38(35):2649\u201362. https:\/\/doi.org\/10.1093\/eurheartj\/ehx321.","journal-title":"Eur Heart J"},{"issue":"1","key":"2170_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","volume":"40","author":"JJ Miner","year":"2014","unstructured":"Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51\u201360. https:\/\/doi.org\/10.1016\/j.rdc.2013.10.003.","journal-title":"Rheum Dis Clin North Am"},{"issue":"21","key":"2170_CR16","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.jacc.2016.07.785","volume":"68","author":"PC Cremer","year":"2016","unstructured":"Cremer PC, Kumar A, Kontzias A, et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol. 2016;68(21):2311\u201328. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.785.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2170_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11739-018-1842-x","volume":"13","author":"A Brucato","year":"2018","unstructured":"Brucato A, Emmi G, Cantarini L, et al. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med. 2018;13(4):475\u201389. https:\/\/doi.org\/10.1007\/s11739-018-1842-x.","journal-title":"Intern Emerg Med"},{"issue":"3","key":"2170_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ijcard.2004.06.012","volume":"102","author":"A Brucato","year":"2005","unstructured":"Brucato A, Brambilla G. Recurrent idiopathic pericarditis: familial occurrence. Int J Cardiol. 2005;102(3):529. https:\/\/doi.org\/10.1016\/j.ijcard.2004.06.012.","journal-title":"Int J Cardiol"},{"issue":"11","key":"2170_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.autrev.2013.04.001","volume":"12","author":"G Wildner","year":"2013","unstructured":"Wildner G, Kaufmann U. What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells. Autoimmun Rev. 2013;12(11):1070\u20135. https:\/\/doi.org\/10.1016\/j.autrev.2013.04.001.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2170_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/hrt.2009.187138","volume":"96","author":"AL Caforio","year":"2010","unstructured":"Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96(10):779\u201384. https:\/\/doi.org\/10.1136\/hrt.2009.187138.","journal-title":"Heart"},{"issue":"3","key":"2170_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10741-012-9334-y","volume":"18","author":"AD Risti\u0107","year":"2013","unstructured":"Risti\u0107 AD, Pankuweit S, Maksimovi\u0107 R, Moosdorf R, Maisch B. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev. 2013;18(3):345\u201353. https:\/\/doi.org\/10.1007\/s10741-012-9334-y.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2170_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000324309","volume":"118","author":"G Lazaros","year":"2011","unstructured":"Lazaros G, Karavidas A, Spyropoulou M, et al. The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Cardiology. 2011;118(1):55\u201362. https:\/\/doi.org\/10.1159\/000324309.","journal-title":"Cardiology"},{"issue":"6","key":"2170_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","volume":"13","author":"D Rigante","year":"2017","unstructured":"Rigante D. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Rev Clin Immunol. 2017;13(6):571\u201397. https:\/\/doi.org\/10.1080\/1744666X.2017.1280396.","journal-title":"Expert Rev Clin Immunol"},{"key":"2170_CR24","doi-asserted-by":"publisher","first-page":"194864","DOI":"10.1155\/2015\/194864","volume":"2015","author":"G Lopalco","year":"2015","unstructured":"Lopalco G, Cantarini L, Vitale A, Iannone F, Anelli MG, Andreozzi L, Lapadula G, Galeazzi M, Rigante D. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm. 2015;2015:194864. https:\/\/doi.org\/10.1155\/2015\/194864.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"2170_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tcm.2020.04.006","volume":"31","author":"G Lopalco","year":"2021","unstructured":"Lopalco G, Rigante D, Cantarini L, et al. The autoinflammatory side of recurrent pericarditis: enlightening the pathogenesis for a more rational treatment. Trends Cardiovasc Med. 2021;31(5):265\u201374. https:\/\/doi.org\/10.1016\/j.tcm.2020.04.006.","journal-title":"Trends Cardiovasc Med"},{"key":"2170_CR26","doi-asserted-by":"publisher","first-page":"948154","DOI":"10.1155\/2014\/948154","volume":"2014","author":"D Rigante","year":"2014","unstructured":"Rigante D, Lopalco G, Vitale A, et al. Untangling the web of systemic autoinflammatory diseases. Mediators Inflamm. 2014;2014:948154. https:\/\/doi.org\/10.1155\/2014\/948154.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2170_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.autrev.2014.10.005","volume":"14","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Lopalco G, Selmi C, et al. Autoimmunity and autoinflammation as the Yin and Yang of idiopathic recurrent acute pericarditis. Autoimmun Rev. 2015;14(2):90\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.005.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2170_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28(1):51. https:\/\/doi.org\/10.1186\/s11658-023-00462-9","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"2170_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248\u201361. https:\/\/doi.org\/10.1038\/nri.2017.10.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2170_CR30","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1002\/jcp.27436","volume":"234","author":"A Bonaventura","year":"2019","unstructured":"Bonaventura A, Montecucco F. Inflammation and pericarditis: are neutrophils actors behind the scenes? J Cell Physiol. 2019;234(5):5390\u20138. https:\/\/doi.org\/10.1002\/jcp.27436.","journal-title":"J Cell Physiol"},{"issue":"8","key":"2170_CR31","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/cvr\/cvz084","volume":"115","author":"A Bonaventura","year":"2019","unstructured":"Bonaventura A, Montecucco F, Dallegri F, et al. Novel findings in neutrophil biology and their impact on cardiovascular disease. Cardiovasc Res. 2019;115(8):1266\u201385. https:\/\/doi.org\/10.1093\/cvr\/cvz084.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2170_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134\u201347. https:\/\/doi.org\/10.1038\/nri.2017.105.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2170_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani A, Garlanda C. Humoral innate immunity and Acute-Phase proteins. N Engl J Med. 2023;388(5):439\u201352. https:\/\/doi.org\/10.1056\/NEJMra2206346.","journal-title":"N Engl J Med"},{"key":"2170_CR34","doi-asserted-by":"publisher","unstructured":"Pepys MB. GM Hirschfield 2003\u00a0C-reactive protein: a critical update [published correction appears in J Clin Invest. 2003;112(2):299]. J Clin Invest 111 12 1805\u201312 https:\/\/doi.org\/10.1172\/JCI18921.","DOI":"10.1172\/JCI18921"},{"issue":"10","key":"2170_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.110.986372","volume":"123","author":"M Imazio","year":"2011","unstructured":"Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123(10):1092\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.986372.","journal-title":"Circulation"},{"issue":"4","key":"2170_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","volume":"52","author":"LA Blauwet","year":"2010","unstructured":"Blauwet LA, Cooper LT, Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274\u201388. https:\/\/doi.org\/10.1016\/j.pcad.2009.11.006.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"2170_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2007.10.053","volume":"127","author":"M Imazio","year":"2008","unstructured":"Imazio M, Trinchero R, Myopericarditis. Etiology, management, and prognosis. Int J Cardiol. 2008;127(1):17\u201326. https:\/\/doi.org\/10.1016\/j.ijcard.2007.10.053.","journal-title":"Int J Cardiol"},{"key":"2170_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2023.03.034","volume":"113","author":"AM Pisacreta","year":"2023","unstructured":"Pisacreta AM, Mascolo R, Nivuori M, et al. Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: a systemic autoinflammatory disease? A cohort study. Eur J Intern Med. 2023;113:45\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2023.03.034.","journal-title":"Eur J Intern Med"},{"issue":"24","key":"2170_CR39","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.3390\/jcm10245837","volume":"10","author":"H Enocsson","year":"2021","unstructured":"Enocsson H, Karlsson J, Li HY, Wu Y, Kushner I, Wetter\u00f6 J, Sj\u00f6wall C. The Complex role of C-Reactive protein in systemic Lupus Erythematosus. J Clin Med. 2021;10(24):5837. https:\/\/doi.org\/10.3390\/jcm10245837.","journal-title":"J Clin Med"},{"issue":"11","key":"2170_CR40","first-page":"747","volume":"21","author":"A Mager","year":"2019","unstructured":"Mager A, Hammer Y, Ofek H, Kedmi I, Iakobishvili Z, Kornowski R. Prognostic and diagnostic significance of serum high-sensitivity C-Reactive protein level in patients with Acute Idiopathic Pericarditis. Isr Med Assoc J. 2019;21(11):747\u201351.","journal-title":"Isr Med Assoc J"},{"issue":"5","key":"2170_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","volume":"62","author":"O Yousuf","year":"2013","unstructured":"Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397\u2013408. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.016.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2170_CR42","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/2047487319879534","volume":"27","author":"M Imazio","year":"2020","unstructured":"Imazio M, Andreis A, De Ferrari GM, et al. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study. Eur J Prev Cardiol. 2020;27(9):956\u201364. https:\/\/doi.org\/10.1177\/2047487319879534.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"2170_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FJC.0000000000000847","volume":"76","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF, Buckley LF, Vecchi\u00e9 A, et al. Acute effects of Interleukin-1 blockade using Anakinra in patients with Acute Pericarditis. J Cardiovasc Pharmacol. 2020;76(1):50\u20132. https:\/\/doi.org\/10.1097\/FJC.0000000000000847.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"2170_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","volume":"384","author":"AL Klein","year":"2021","unstructured":"Klein AL, Imazio M, Cremer P, et al. Phase 3 trial of Interleukin-1 trap rilonacept in recurrent Pericarditis. N Engl J Med. 2021;384(1):31\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2027892.","journal-title":"N Engl J Med"},{"issue":"18","key":"2170_CR45","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato A, Imazio M, Gattorno M, et al. Effect of Anakinra on recurrent Pericarditis among patients with Colchicine Resistance and Corticosteroid Dependence: the AIRTRIP Randomized Clinical Trial. JAMA. 2016;316(18):1906\u201312. https:\/\/doi.org\/10.1001\/jama.2016.15826.","journal-title":"JAMA"},{"issue":"7","key":"2170_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/eurheartj\/ehi045","volume":"26","author":"B Maisch","year":"2005","unstructured":"Maisch B. Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J. 2005;26(7):631\u20133. https:\/\/doi.org\/10.1093\/eurheartj\/ehi045.","journal-title":"Eur Heart J"},{"issue":"21","key":"2170_CR47","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","volume":"115","author":"M Imazio","year":"2007","unstructured":"Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.662114.","journal-title":"Circulation"},{"key":"2170_CR48","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.12659\/MSM.892139","volume":"20","author":"\u00dc Uluca","year":"2014","unstructured":"Uluca \u00dc, Ece A, \u015een V, Karabel D, Yel S, G\u00fcne\u015f A, Tan I, Sabas M. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with familial Mediterranean fever. Med Sci Monit. 2014;20:1578\u201382. https:\/\/doi.org\/10.12659\/MSM.892139.","journal-title":"Med Sci Monit"},{"issue":"4","key":"2170_CR49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcmg.2017.06.017","volume":"11","author":"KH Kim","year":"2018","unstructured":"Kim KH, Miranda WR, Sinak LJ, et al. Effusive-constrictive Pericarditis after Pericardiocentesis: incidence, Associated findings, and natural history. JACC Cardiovasc Imaging. 2018;11(4):534\u201341. https:\/\/doi.org\/10.1016\/j.jcmg.2017.06.017.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2170_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjcard.2006.01.086","volume":"98","author":"A Brucato","year":"2006","unstructured":"Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol. 2006;98(2):267\u201371. https:\/\/doi.org\/10.1016\/j.amjcard.2006.01.086.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2170_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11739-019-02041-3","volume":"14","author":"G Lazaros","year":"2019","unstructured":"Lazaros G, Antonopoulos AS, Imazio M, et al. Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis. Intern Emerg Med. 2019;14(5):745\u201351. https:\/\/doi.org\/10.1007\/s11739-019-02041-3.","journal-title":"Intern Emerg Med"},{"issue":"Suppl 1","key":"2170_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00393-023-01412-8","volume":"83","author":"YH Lee","year":"2024","unstructured":"Lee YH, Song GG. Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential biomarkers in Beh\u00e7et\u2019s disease: a meta-analysis. Die Rolle Des Neutrophilen-Lymphozyten-Verh\u00e4ltnisses und des thrombozyten-Lymphozyten-Verh\u00e4ltnisses als potenzielle Biomarker bei Morbus Beh\u00e7et: Eine Metaanalyse. Z Rheumatol. 2024;83(Suppl 1):206\u201313. https:\/\/doi.org\/10.1007\/s00393-023-01412-8.","journal-title":"Z Rheumatol"},{"key":"2170_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jns.2018.01.038","volume":"387","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi S, Cagnetti C, Rinaldi C, Angelocola S, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage. J Neurol Sci. 2018;387:98\u2013102. https:\/\/doi.org\/10.1016\/j.jns.2018.01.038.","journal-title":"J Neurol Sci"},{"issue":"9","key":"2170_CR54","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/life12091415","volume":"12","author":"S Lattanzi","year":"2022","unstructured":"Lattanzi S, Norata D, Broggi S, et al. Neutrophil-to-lymphocyte ratio predicts early neurological deterioration after Endovascular Treatment in patients with ischemic stroke. Life (Basel). 2022;12(9):1415. https:\/\/doi.org\/10.3390\/life12091415.","journal-title":"Life (Basel)"},{"issue":"48","key":"2170_CR55","doi-asserted-by":"publisher","first-page":"e13471","DOI":"10.1097\/MD.0000000000013471","volume":"97","author":"JS Park","year":"2018","unstructured":"Park JS, Seo KW, Choi BJ, et al. Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction. Med (Baltim). 2018;97(48):e13471. https:\/\/doi.org\/10.1097\/MD.0000000000013471.","journal-title":"Med (Baltim)"},{"issue":"19","key":"2170_CR56","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.3346\/jkms.2021.36.e131","volume":"36","author":"GS Yoon","year":"2021","unstructured":"Yoon GS, Choi SH, Woo SI, Baek YS, Park SD, Shin SH, Kim DH, Kwan J, Lee MJ, Kwon SW. Neutrophil-to-lymphocyte ratio at Emergency Room predicts mechanical complications of ST-segment elevation myocardial infarction. J Korean Med Sci. 2021;36(19):e131. https:\/\/doi.org\/10.3346\/jkms.2021.36.e131.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"2170_CR57","doi-asserted-by":"publisher","first-page":"R192","DOI":"10.1186\/cc9309","volume":"14","author":"CP de Jager","year":"2010","unstructured":"de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. https:\/\/doi.org\/10.1186\/cc9309.","journal-title":"Crit Care"},{"issue":"5","key":"2170_CR58","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/00015385.2021.1951998","volume":"77","author":"F Y\u0131lmaz","year":"2022","unstructured":"Y\u0131lmaz F, Y\u0131lmaz FK, Karag\u00f6z A, et al. Usefulness of neutrophil-to-lymphocyte ratio for predicting acute pericarditis outcomes. Acta Cardiol. 2022;77(5):422\u201330. https:\/\/doi.org\/10.1080\/00015385.2021.1951998.","journal-title":"Acta Cardiol"},{"issue":"1","key":"2170_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13054-015-0778-z","volume":"19","author":"TA Mare","year":"2015","unstructured":"Mare TA, Treacher DF, Shankar-Hari M et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care. 2015;19(1):57. https:\/\/doi.org\/10.1186\/s13054-015-0778-z","journal-title":"Crit Care"},{"issue":"16\u201317","key":"2170_CR60","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.clinbiochem.2017.05.014","volume":"50","author":"BS Karon","year":"2017","unstructured":"Karon BS, Tolan NV, Wockenfus AM, et al. Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem. 2017;50(16\u201317):956\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.05.014.","journal-title":"Clin Biochem"},{"key":"2170_CR61","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcrc.2018.12.002","volume":"50","author":"Y Huang","year":"2019","unstructured":"Huang Y, Xiao J, Cai T, et al. Immature granulocytes: a novel biomarker of acute respiratory distress syndrome in patients with acute pancreatitis. J Crit Care. 2019;50:303\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2018.12.002.","journal-title":"J Crit Care"},{"issue":"9","key":"2170_CR62","doi-asserted-by":"publisher","first-page":"794","DOI":"10.5005\/jp-journals-10071-23563","volume":"24","author":"C Bedel","year":"2020","unstructured":"Bedel C, Korkut M, Avc\u0131 A, Uzun A. Immature Granulocyte Count and percentage as New predictors of Mortality in patients with Upper gastrointestinal bleeding. Indian J Crit Care Med. 2020;24(9):794\u20138. https:\/\/doi.org\/10.5005\/jp-journals-10071-23563.","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"2170_CR63","first-page":"e73","volume":"8","author":"C Bedel","year":"2020","unstructured":"Bedel C, Korkut M, Aksoy F, Ku\u015f G. Usefulness of immature granulocytes to predict high coronary SYNTAX score in Acute Coronary Syndrome; a cross-sectional study. Arch Acad Emerg Med. 2020;8(1):e73.","journal-title":"Arch Acad Emerg Med"},{"key":"2170_CR64","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.3390\/jcm13195944","volume":"13","author":"F Casarin","year":"2024","unstructured":"Casarin F, Mascolo R, Motta I, Wu MA, Bizzi E, Pedroli A, Dieguez G, Iacomelli G, Serati L, Duca L, et al. Decrease in hemoglobin levels during acute attacks in patients with idiopathic recurrent pericarditis: a model of Anemia in Acute Disease. J Clin Med. 2024;13:5944. https:\/\/doi.org\/10.3390\/jcm13195944.","journal-title":"J Clin Med"},{"issue":"1","key":"2170_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40\u201350. https:\/\/doi.org\/10.1182\/blood-2018-06-856500.","journal-title":"Blood"},{"issue":"19","key":"2170_CR66","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW. A test in Context: D-Dimer. J Am Coll Cardiol. 2017;70(19):2411\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.024.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2170_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2013.07.012","volume":"25","author":"G Lippi","year":"2014","unstructured":"Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25(1):45\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2013.07.012.","journal-title":"Eur J Intern Med"},{"key":"2170_CR68","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/OAEM.S238696","volume":"13","author":"F Innocenti","year":"2021","unstructured":"Innocenti F, Lazzari C, Ricci F, Paolucci E, Agishev I, Pini R. D-Dimer tests in the emergency department: current insights. Open Access Emerg Med. 2021;13:465\u201379. https:\/\/doi.org\/10.2147\/OAEM.S238696","journal-title":"Open Access Emerg Med"},{"issue":"5","key":"2170_CR69","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/2048872616652309","volume":"5","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Lyon A, Saggar R, et al. Editor\u2019s choice-biomarkers of acute cardiovascular and pulmonary diseases. Eur Heart J Acute Cardiovasc Care. 2016;5(5):416\u201333. https:\/\/doi.org\/10.1177\/2048872616652309.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"5","key":"2170_CR70","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/2048872620907322","volume":"10","author":"V Koch","year":"2021","unstructured":"Koch V, Biener M, M\u00fcller-Hennessen M, et al. Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection. Eur Heart J Acute Cardiovasc Care. 2021;10(5):559\u201366. https:\/\/doi.org\/10.1177\/2048872620907322.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"2170_CR71","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666\u201382. https:\/\/doi.org\/10.1038\/s41569-021-00552-1.","journal-title":"Nat Rev Cardiol"},{"key":"2170_CR72","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s11739-024-03712-6","volume":"19","author":"A Mauro","year":"2024","unstructured":"Mauro A, Bizzi E, Wu MA, et al. D-Dimer and procalcitonin in patients with recurrent pericarditis: a prospective study. Intern Emerg Med. 2024;19:2133\u20132139. https:\/\/doi.org\/10.1007\/s11739-024-03712-6","journal-title":"Intern Emerg Med"},{"issue":"9_Supplement_1","key":"2170_CR73","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0735-1097(19)31591-8","volume":"73","author":"C Ala","year":"2019","unstructured":"Ala C, Banerjee K, Chahine J, et al. D-Dimer as a novel, marker of inflammation in pericarditis. JACC. 2019;73(9_Supplement_1):984. https:\/\/www.jacc.org\/doi\/10.1016\/S0735-1097%2819%2931591-8","journal-title":"JACC"},{"issue":"9","key":"2170_CR74","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.v98.9.2720","volume":"98","author":"A Kaser","year":"2001","unstructured":"Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98(9):2720\u20135. https:\/\/doi.org\/10.1182\/blood.v98.9.2720.","journal-title":"Blood"},{"key":"2170_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejim.2023.07.028","volume":"116","author":"MA Wu","year":"2023","unstructured":"Wu MA, Bizzi E, Brucato A. Inflammatory puzzle: unveiling the role of D-Dimer in acute pericarditis and thromboinflammation. Eur J Intern Med. 2023;116:41\u20132. https:\/\/doi.org\/10.1016\/j.ejim.2023.07.028.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"2170_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/ijabmr.ijabmr_802_21","volume":"12","author":"E Begi\u0107","year":"2022","unstructured":"Begi\u0107 E, Iglica A, Gojak R, et al. Pericardial Effusion in Postcoronavirus Disease patients with preserved ejection fraction of the left ventricle and normal values of N-Terminal-pro B-Type natriuretic peptide-link with C-Reactive protein and D-Dimer. Int J Appl Basic Med Res. 2022;12(3):157\u201360. https:\/\/doi.org\/10.4103\/ijabmr.ijabmr_802_21.","journal-title":"Int J Appl Basic Med Res"},{"issue":"9","key":"2170_CR77","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jacbts.2023.03.017","volume":"8","author":"N Potere","year":"2023","unstructured":"Potere N, Abbate A, Kanthi Y, et al. Inflammasome Signaling, Thromboinflammation, and venous thromboembolism. JACC Basic Transl Sci. 2023;8(9):1245\u201361. https:\/\/doi.org\/10.1016\/j.jacbts.2023.03.017.","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"2170_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13018-018-0730-4","volume":"13","author":"YS Lee","year":"2018","unstructured":"Lee YS, Lee YK, Han SB, Nam CH, Parvizi J, Koo KH. Natural progress of D-dimer following total joint arthroplasty: a baseline for the diagnosis of the early postoperative infection. J Orthop Surg Res. 2018;13(1):36. https:\/\/doi.org\/10.1186\/s13018-018-0730-4.","journal-title":"J Orthop Surg Res"},{"issue":"10","key":"2170_CR79","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/euhj.1999.1907","volume":"21","author":"E Bonnefoy","year":"2000","unstructured":"Bonnefoy E, Godon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J. 2000;21(10):832\u20136. https:\/\/doi.org\/10.1053\/euhj.1999.1907.","journal-title":"Eur Heart J"},{"issue":"11","key":"2170_CR80","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/s0002-9149(01)01536-3","volume":"87","author":"RR Brandt","year":"2001","unstructured":"Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. Am J Cardiol. 2001;87(11):1326\u20138. https:\/\/doi.org\/10.1016\/s0002-9149(01)01536-3.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2170_CR81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2459\/JCM.0b013e3283641161","volume":"15","author":"S Gamaza-Chuli\u00e1n","year":"2014","unstructured":"Gamaza-Chuli\u00e1n S, Le\u00f3n-Jim\u00e9nez J, Recuerda-N\u00fa\u00f1ez M, Camacho-Freire S, Guti\u00e9rrez-Barrios A, Vargas-Machuca JC. Cardiac troponin-T in acute pericarditis. J Cardiovasc Med (Hagerstown). 2014;15(1):68\u201372. https:\/\/doi.org\/10.2459\/JCM.0b013e3283641161.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"2170_CR82","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.001531","volume":"128","author":"M Imazio","year":"2013","unstructured":"Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001531.","journal-title":"Circulation"},{"issue":"1","key":"2170_CR83","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/01.CIR.95.1.163","volume":"95","author":"SC Smith","year":"1997","unstructured":"Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95(1):163\u20138.","journal-title":"Circulation"},{"issue":"5","key":"2170_CR84","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/s0735-1097(97)00317-3","volume":"30","author":"B Lauer","year":"1997","unstructured":"Lauer B, Niederau C, K\u00fchl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30(5):1354\u20139. https:\/\/doi.org\/10.1016\/s0735-1097(97)00317-3.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2170_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ancard.2009.07.009","volume":"59","author":"S Machado","year":"2010","unstructured":"Machado S, Roubille F, Gahide G, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris). 2010;59(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ancard.2009.07.009.","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"3","key":"2170_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2459\/JCM.0b013e328351da6e","volume":"14","author":"A Buiatti","year":"2013","unstructured":"Buiatti A, Merlo M, Pinamonti B, De Biasio M, Bussani R, Sinagra G. Clinical presentation and long-term follow-up of perimyocarditis. J Cardiovasc Med (Hagerstown). 2013;14(3):235\u201341. https:\/\/doi.org\/10.2459\/JCM.0b013e328351da6e.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"2170_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ehjcvp\/pvx018","volume":"4","author":"LF Buckley","year":"2018","unstructured":"Buckley LF, Viscusi MM, Van Tassell BW, Abbate A. Interleukin-1 blockade for the treatment of pericarditis. Eur Heart J Cardiovasc Pharmacother. 2018;4(1):46\u201353. https:\/\/doi.org\/10.1093\/ehjcvp\/pvx018.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"7","key":"2170_CR88","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.amjcard.2004.06.046","volume":"94","author":"M Imazio","year":"2004","unstructured":"Imazio M, Demichelis B, Parrini I, et al. Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis. Am J Cardiol. 2004;94(7):973\u20135. https:\/\/doi.org\/10.1016\/j.amjcard.2004.06.046.","journal-title":"Am J Cardiol"},{"issue":"11","key":"2170_CR89","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3324\/haematol.2016.144055","volume":"101","author":"M Bonaccio","year":"2016","unstructured":"Bonaccio M, Di Castelnuovo A, Pounis G, De Curtis A, Costanzo S, Persichillo M, Cerletti C, Donati MB, de Gaetano G, Iacoviello L. Moli-Sani Study investigators. A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-Sani study. Haematologica. 2016;101(11):1434\u201341. https:\/\/doi.org\/10.3324\/haematol.2016.144055.","journal-title":"Haematologica"},{"key":"2170_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2024.03.010","author":"A Andreis","year":"2024","unstructured":"Andreis A, Solano A, Balducci M, et al. INFLA-score: a new diagnostic paradigm to identify pericarditis. Hellenic J Cardiol. 2024;21. https:\/\/doi.org\/10.1016\/j.hjc.2024.03.010","journal-title":"Hellenic J Cardiol"},{"issue":"3","key":"2170_CR91","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.autrev.2013.10.015","volume":"13","author":"N Bizzaro","year":"2014","unstructured":"Bizzaro N, Antico A, Platzgummer S, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev. 2014;13(3):292\u20138. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.015.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2170_CR92","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in healthy individuals. Arthritis Rheum. 1997;40(9):1601\u201311. https:\/\/doi.org\/10.1002\/art.1780400909.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2170_CR93","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/art.34380","volume":"64","author":"M Satoh","year":"2012","unstructured":"Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64(7):2319\u201327. https:\/\/doi.org\/10.1002\/art.34380.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2170_CR94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2012.02.013","volume":"12","author":"K Op De Be\u00e9ck","year":"2012","unstructured":"Op De Be\u00e9ck K, Vermeersch P, Verschueren P, et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. 2012;12(2):137\u201343. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.013.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2170_CR95","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/art.10561","volume":"47","author":"DH Solomon","year":"2002","unstructured":"Solomon DH, Kavanaugh AJ, Schur PH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 2002;47(4):434\u201344. https:\/\/doi.org\/10.1002\/art.10561.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2170_CR96","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijcard.2008.05.020","volume":"136","author":"M Imazio","year":"2009","unstructured":"Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol. 2009;136(3):289\u201393. https:\/\/doi.org\/10.1016\/j.ijcard.2008.05.020.","journal-title":"Int J Cardiol"},{"issue":"9","key":"2170_CR97","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1191\/0961203305lu2197oa","volume":"14","author":"A Brucato","year":"2005","unstructured":"Brucato A, Shinar Y, Brambilla G, et al. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of caucasian patients. Lupus. 2005;14(9):670\u20134. https:\/\/doi.org\/10.1191\/0961203305lu2197oa.","journal-title":"Lupus"},{"issue":"11","key":"2170_CR98","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","volume":"28","author":"AL Caforio","year":"2007","unstructured":"Caforio AL, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007;28(11):1326\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehm076.","journal-title":"Eur Heart J"},{"issue":"8","key":"2170_CR99","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/0002-9149(83)90535-0","volume":"52","author":"B Maisch","year":"1983","unstructured":"Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol. 1983;52(8):1072\u20138. https:\/\/doi.org\/10.1016\/0002-9149(83)90535-0.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2170_CR100","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/01.cir.85.5.1734","volume":"85","author":"AL Caforio","year":"1992","unstructured":"Caforio AL, Grazzini M, Mann JM, et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992;85(5):1734\u201342. https:\/\/doi.org\/10.1161\/01.cir.85.5.1734.","journal-title":"Circulation"},{"issue":"7","key":"2170_CR101","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/0735-1097(90)92821-i","volume":"15","author":"AL Caforio","year":"1990","unstructured":"Caforio AL, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990;15(7):1527\u201334. https:\/\/doi.org\/10.1016\/0735-1097(90)92821-i.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2170_CR102","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1253\/circj.71.186","volume":"71","author":"M Kosuge","year":"2007","unstructured":"Kosuge M, Ebina T, Ishikawa T, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J. 2007;71(2):186\u201390. https:\/\/doi.org\/10.1253\/circj.71.186.","journal-title":"Circ J"},{"issue":"6","key":"2170_CR103","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/01.CIR.0000115516.54550.B1","volume":"109","author":"BD Johnson","year":"2004","unstructured":"Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women\u2019s ischemia syndrome evaluation (WISE). Circulation. 2004;109(6):726\u201332. https:\/\/doi.org\/10.1161\/01.CIR.0000115516.54550.B1.","journal-title":"Circulation"},{"key":"2170_CR104","doi-asserted-by":"publisher","first-page":"631299","DOI":"10.3389\/fimmu.2020.631299","volume":"11","author":"I Sori\u0107 Hosman","year":"2021","unstructured":"Sori\u0107 Hosman I, Kos I, Lamot L. Serum amyloid A in Inflammatory Rheumatic diseases: a compendious review of a renowned biomarker. Front Immunol. 2021;11:631299. https:\/\/doi.org\/10.3389\/fimmu.2020.631299.","journal-title":"Front Immunol"},{"key":"2170_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-019-0783-4","volume":"19","author":"HY Lin","year":"2019","unstructured":"Lin HY, Tan GQ, Liu Y, Lin SQ. The prognostic value of serum amyloid A in solid tumors: a meta-analysis. Cancer Cell Int. 2019;19:62. https:\/\/doi.org\/10.1186\/s12935-019-0783-4.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"2170_CR106","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s11255-024-03959-0","volume":"56","author":"N Cui","year":"2024","unstructured":"Cui N, Zhang YY, Sun T, Lv XW, Dong XM, Chen N. Utilizing procalcitonin, C-reactive protein, and serum amyloid A in combination for diagnosing sepsis due to urinary tract infection. Int Urol Nephrol. 2024;56(7):2141\u20136. https:\/\/doi.org\/10.1007\/s11255-024-03959-0.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"2170_CR107","first-page":"509","volume":"21","author":"A Duzova","year":"2003","unstructured":"Duzova A, Bakkaloglu A, Besbas N, et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol. 2003;21(4):509\u201314.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"2170_CR108","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836\u201343. https:\/\/doi.org\/10.1056\/NEJM200003233421202.","journal-title":"N Engl J Med"},{"issue":"11","key":"2170_CR109","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s10067-016-3275-0","volume":"35","author":"FM Kelesoglu","year":"2016","unstructured":"Kelesoglu FM, Aygun E, Okumus NK, et al. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol. 2016;35(11):2757\u201363. https:\/\/doi.org\/10.1007\/s10067-016-3275-0.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2170_CR110","first-page":"207","volume":"31","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Brucato A, Simonini G, et al. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report. Clin Exp Rheumatol. 2013;31(2):207\u201312.","journal-title":"Clin Exp Rheumatol"},{"key":"2170_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02390-w","author":"D Kaudewitz","year":"2024","unstructured":"Kaudewitz D, John L, Meis J, et al. Clinical and serological characterization of acute pleuropericarditis suggests an autoinflammatory pathogenesis and highlights risk factors for recurrent attacks. Clin Res Cardiol. 2024. https:\/\/doi.org\/10.1007\/s00392-024-02390-w.","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2170_CR112","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/HJR.0b013e32833b09d9","volume":"18","author":"SG Wannamethee","year":"2011","unstructured":"Wannamethee SG, Welsh P, Whincup PH, et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil. 2011;18(1):65\u201371. https:\/\/doi.org\/10.1097\/HJR.0b013e32833b09d9.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"6","key":"2170_CR113","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1365-2265.2008.03248.x","volume":"69","author":"M Zhong","year":"2008","unstructured":"Zhong M, Tan HW, Gong HP, Wang SF, Zhang Y, Zhang W. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol (Oxf). 2008;69(6):878\u201384. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03248.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2170_CR114","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932\u20139. https:\/\/doi.org\/10.1161\/01.CIR.0000155620.10387.43.","journal-title":"Circulation"},{"issue":"14","key":"2170_CR115","doi-asserted-by":"publisher","first-page":"17885","DOI":"10.18632\/oncotarget.7530","volume":"7","author":"G Markel","year":"2016","unstructured":"Markel G, Imazio M, Koren-Morag N, et al. CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis. Oncotarget. 2016;7(14):17885\u201395. https:\/\/doi.org\/10.18632\/oncotarget.7530.","journal-title":"Oncotarget"},{"issue":"11","key":"2170_CR116","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/cells8111352","volume":"8","author":"M Mirna","year":"2019","unstructured":"Mirna M, Paar V, Rezar R, et al. MicroRNAs in Inflammatory Heart diseases and Sepsis-Induced Cardiac Dysfunction: a potential scope for the future? Cells. 2019;8(11):1352. https:\/\/doi.org\/10.3390\/cells8111352.","journal-title":"Cells"},{"issue":"6","key":"2170_CR117","doi-asserted-by":"publisher","first-page":"e032516","DOI":"10.1161\/JAHA.123.032516","volume":"13","author":"M Imazio","year":"2024","unstructured":"Imazio M, Klein AL, Brucato A, et al. Sustained Pericarditis Recurrence Risk Reduction with Long-Term Rilonacept. J Am Heart Assoc. 2024;13(6):e032516. https:\/\/doi.org\/10.1161\/JAHA.123.032516.","journal-title":"J Am Heart Assoc"},{"key":"2170_CR118","doi-asserted-by":"crossref","unstructured":"Brucato A, Ceriani E, Agozzino F et al. Duration of Disease and Long-Term outcomes in patients with difficult-to-treat recurrent pericarditis: a chronic Condition treated with NSAIDs, Colchicine, corticosteroids, and Anti-IL-1 agents [abstract]. Arthritis Rheumatol 2024; 76 (suppl 9). acrabstracts.org\/abstract\/duration-of-disease-and-long-term-outcomes-in-patients-with-difficult-to-treat-recurrent-pericarditis-a-chronic-condition-treated-with-nsaids-colchicine-corticosteroids-and-anti-il-1-agents\/","DOI":"10.1002\/acr2.11776"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02170-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:58:47Z","timestamp":1772096327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02170-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02170-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"7 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies with human or animal subjects are published and followed ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17"}}